This guidance helps clinical investigators understand what needs to be included in a submission notifying the MHRA of a manufacturer’s plans to undertake a clinical investigation, including our approval process, conduct, labelling of devices and what documentation you need to provide.
Excerpt from the official page. The original is authoritative.